Q-omics provides the consensus-scored SCAND3P1 profile across patient tissues and cancer cell-line models. SCAND3P1 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, SCAND3P1 is differentially expressed in 5, with the highest sampling consensus in KICH. Additionally, SCAND3P1 RNA expression shows 11,070 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KIRC, KICH, and GBM as cancer lineages where SCAND3P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SCAND3P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SCAND3P1 survival associations across molecular data types. SCAND3P1 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SCAND3P1 RNA expression–survival associations across cancer types. High SCAND3P1 expression shows unfavorable associations in KIRC, ACC, HNSC, THYM and KICH, but favorable associations in SKCM. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for SCAND3P1 RNA expression.
This table summarizes SCAND3P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for SCAND3P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SCAND3P1 shows lower tumor expression in KICH and KIRP and higher tumor expression in THCA, BRCA and UCEC. The KICH box plot shows higher SCAND3P1 RNA expression in normal versus tumor tissue (log2 FC = −0.052, t-test p = .002).
This table shows molecular features associated with SCAND3P1 in patient tissues and cancer cell lines. In patient samples, SCAND3P1 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
